Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1320 Neoplasms 983 Carcinoma, Non-Small-Cell Lung 858 Prostatic Neoplasms 723 Colorectal Neoplasms 662 Lung Neoplasms 548 Leukemia, Myeloid, Acute 475 Neoplasm Metastasis 431 Pancreatic Neoplasms 418 Carcinoma, Hepatocellular 406 Multiple Myeloma 397 Ovarian Neoplasms 391 Stomach Neoplasms 378 Recurrence 365 Squamous Cell Carcinoma of Head and Neck 325 Melanoma 293 Brain Neoplasms 287 Uterine Cervical Neoplasms 283 Triple Negative Breast Neoplasms 271 Head and Neck Neoplasms 263 Glioblastoma 263 Precursor Cell Lymphoblastic Leukemia-Lymphoma 254 Endometrial Neoplasms 233 Lymphoma 227 Esophageal Neoplasms 222 Rectal Neoplasms 221 Sarcoma 211 Carcinoma, Renal Cell 203 Colonic Neoplasms 193 Lymphoma, Large B-Cell, Diffuse 191

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × Pancreatic Cystic Neoplasm × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡